Neurotune AG
π¨πSwitzerland
- Country
- π¨πSwitzerland
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.neurotune.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 2
2 (100.0%)Dimiracetam in Painful Neuropathies Affecting AIDS Patients
Phase 2
- Conditions
- Acquired Immunodeficiency Syndrome
- Interventions
- First Posted Date
- 2011-10-03
- Last Posted Date
- 2011-10-03
- Lead Sponsor
- Neurotune AG
- Target Recruit Count
- 244
- Registration Number
- NCT01444690
- Locations
- π¨π
Neurotune AG, Lugano, Switzerland
Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy
- First Posted Date
- 2010-06-02
- Last Posted Date
- 2010-06-02
- Lead Sponsor
- Neurotune AG
- Target Recruit Count
- 116
- Registration Number
- NCT01135251
- Locations
- πΏπ¦
Aurora Hospital Triple Research, Port Elizabeth, South Africa
News
No news found